data_lhomme_et_al_behavioralecology

Raw data used in the Figures 2, 3 and

Baseline characteristics of the study sample.

<p>Baseline characteristics of the study sample.</p

Diagnostic test analysis of the gold standard test (at both the VL cutoffs of 5000 and 1000 copies/mL) and the CD4⁺ test adjusted for confounders at 12, 18, and 24 months.

<p>Results are shown as point estimates and [95% CI].</p

ART treatment failure identification from different definitions.

<p>The viral load definitions were considered as gold standard, and the WHO criteria from CD4⁺ as the new test.</p

Diagnostic test indexes of the gold standard test (VL > 5000 copies/mL and VL ≥ 1000 copies/mL) and the CD4⁺ test at 12, 18, and 24 months.

<p>The absolute estimates with their 95% CIs are also shown.</p

Comparison between the gold standard tests and the CD4⁺ test at the 12th, 18th, and 24th months.

<p>Comparison between the gold standard tests and the CD4⁺ test at the 12th, 18th, and 24th months.</p

~174 kb plasmid identified in isolates L1, L3 and L4.

The x-axis shows the size of plasmids in kb and the y-axis is the normalized intensity in arbitrary units, where the intensity plot of each isolate is shifted vertically by five units for clarity. (DOCX)</p

A timeline to illustrate the conception and implementation of the VINARES project.

<p>GARP, Global Antibiotic Resistance Partnership; LiU, Linköping University; OUCRU, Oxford University Clinical Research Unit; UK NEQAS, United Kingdom National External Quality Assessment Service.</p

Drivers of antibiotic resistance, hospital-related WHO policy package priorities, and how these are met by the VINARES project [10].

<p>Drivers of antibiotic resistance, hospital-related WHO policy package priorities, and how these are met by the VINARES project <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001429#pmed.1001429-Leung1" target="_blank">[10]</a>.</p

Location, speciality, and type of the 16 participating hospitals in the VINARES project.

<p>Location, speciality, and type of the 16 participating hospitals in the VINARES project.</p